Aptevo Therapeutics Profit Margin

Aptevo Therapeutics (APVO) currently reports a profit margin of 13320.91% as of March 2026. That is above the Healthcare sector average of 15.29%. Use the charts on this page to explore Aptevo Therapeutics's profit margin history and peer comparisons.

Aptevo Therapeutics's profit margin of 13320.91% is higher than the Healthcare sector average of 15.29%. That is roughly 87005.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Aptevo Therapeutics's current 13320.91% should be judged against Healthcare norms (sector average: 15.29%) and against APVO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 13320.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Aptevo Therapeutics, and consider following APVO for alerts when major investors trade the stock.

Aptevo Therapeutics is classified in the Healthcare sector. On profit margin, it currently shows 13320.91% versus a sector average near 15.29%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APVO with unrelated industries.